Baxter International | BAX - Ebitda


Baxter International reported $309M in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
Abbott USD 2.43B 844M Mar/2026
AngioDynamics USD 5.94M 3.78M Sep/2025
Artivion USD 22.72M 1.84M Dec/2025
AtriCure USD 27.28M 10.21M Jun/2026
Baxter International USD 309M 756M Mar/2026
Becton, Dickinson and Co. USD 1.71B 1B Jun/2026
Boston Scientific USD 1.63B 27M Jun/2026
Cooper Companies USD 323.4M 13.2M Dec/2025
Dexcom USD 364.5M 57.7M Mar/2026
Edwards Lifesciences USD 555.6M 485.5M Mar/2026
Fresenius EUR 988M 37M Jun/2026
Globus Medical USD 231.83M 48.62M Mar/2026
Halozyme Therapeutics USD 219.57M 197.66M Mar/2026
ICU Medical USD 98.68M 489K Mar/2026
Insulet USD 199.8M 18.1M Jun/2026
Integra LifeSciences USD 78.41M 2.23M Jun/2026
Intuitive Surgical USD 1.06B 29.9M Mar/2026
J&J USD 8.27B 1.08B Mar/2026
Laboratory Of America USD 767.7M 162.1M Jun/2026
Medtronic USD 2.81B 119M Mar/2026
Merit Medical Systems USD 104.39M 10.97M Jun/2026
Quest Diagnostics USD 648M 91M Jun/2026
Smith & Nephew USD 796M 139M Dec/2025
Stryker USD 1.93B 357M Jun/2026
Tandem Diabetes Care USD 2.73M 30.17M Mar/2026
Teleflex USD 75.63M 171.44M Mar/2026
Terumo JPY 57.88B 12.1B Mar/2026
Zimmer Biomet Holdings USD 830.5M 190.4M Jun/2026